Ginkgo bioworks receives grant to develop innovative live cell delivery platform of antibody therapeutics for treating hiv and malaria
Ginkgo, under a grant from the bill & melinda gates foundation, will work to develop a live cell therapeutic that can produce antibodies to fight human immunodeficiency virus (hiv) and/or malaria directly in the body ginkgo will apply its cell engineering expertise towards creating a fundamentally new cell-based therapeutic delivery modality which could change the future of biologics delivery in medicine boston , dec. 13, 2023 /prnewswire/ -- – ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, has received a grant from the bill & melinda gates foundation to develop a novel cell-based technology for improving protein therapeutics delivery for patients in low- and middle-income countries (lmics). protein therapeutics have transformed the standard of care for many diseases — the best known example being insulin for diabetes — and have helped to extend lives across the world, thanks to revolutionizing treatments of diseases such as anemia, cancers, and certain genetic disorders.
DNA Ratings Summary
DNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission